The information was given on 28 August by the Assistant Secretary of State and Health at the usual press conference on Covid-19, highlighting that this investment of 361 million Euros served to give the SNS "more responsiveness and resilience, more human resources and equipment" in this phase of the fight against the Covid-19 pandemic.

"The financial execution of the SNS reveals that, compared to the same period in 2019, in July 2020 there was an evident increase in financial resources of around 361 million Euros in the first seven months of the year," she said.

Of these 361 million distributed by the various branches of the SNS, the government highlighted the 165.1 million Euros for personnel expenses, another 48 million for pharmaceutical products expenses, another 47 million in clinical consumption material, another 52.4 million in products sold by pharmacies and a further 90.9 million in investment.

"The SNS also managed to reduce the volume of arrears to the lowest number of the last 10 years, reducing by around 311 million, that is, by 55.6 percent less than in the same period in 2019," she said.

For Jamila Madeira, in relation to the fight against Covid-19, "all the results obtained so far have been developed by all SNS entities and, first and foremost, the dedication and commitment of all professionals".